PMC:7556165 / 1378-1647
Annnotations
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T4 | 142-145 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | ACE | http://purl.bioontology.org/ontology/MEDDRA/10050289 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4 | 161-172 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T14 | 29-38 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
T15 | 29-33 | Species | denotes | SARS | NCBItxid:694009 |
T16 | 248-258 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T17 | 248-252 | Species | denotes | SARS | NCBItxid:694009 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-269 | Sentence | denotes | Owing to the role of ACE2 in SARS-CoV2 pathogenicity, it has been speculated that medical conditions, i.e., hypertension, and/or drugs, i.e., ACE inhibitors and angiotensin receptor blockers, known to influence ACE2 density could alter the fate of SARS-CoV-2 infection. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
58 | 21-25 | Gene | denotes | ACE2 | Gene:59272 |
59 | 142-145 | Gene | denotes | ACE | Gene:1636 |
60 | 211-215 | Gene | denotes | ACE2 | Gene:59272 |
76 | 29-38 | Species | denotes | SARS-CoV2 | Tax:2697049 |
83 | 108-120 | Disease | denotes | hypertension | MESH:D006973 |
84 | 248-268 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T109 | 21-25 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T110 | 142-145 | Protein | denotes | ACE | https://www.uniprot.org/uniprot/Q9GLN7|https://www.uniprot.org/uniprot/Q9GLN6|https://www.uniprot.org/uniprot/Q9EQM9|https://www.uniprot.org/uniprot/Q8CFN1|https://www.uniprot.org/uniprot/Q7TMC6|https://www.uniprot.org/uniprot/Q7M4L4|https://www.uniprot.org/uniprot/Q6GTS2|https://www.uniprot.org/uniprot/Q59GY8|https://www.uniprot.org/uniprot/Q53YX9|https://www.uniprot.org/uniprot/Q50JE5|https://www.uniprot.org/uniprot/Q10751|https://www.uniprot.org/uniprot/Q0GA41|https://www.uniprot.org/uniprot/P47820|https://www.uniprot.org/uniprot/P22968|https://www.uniprot.org/uniprot/P22967|https://www.uniprot.org/uniprot/P22966|https://www.uniprot.org/uniprot/P12822|https://www.uniprot.org/uniprot/P12821|https://www.uniprot.org/uniprot/P12820|https://www.uniprot.org/uniprot/P09470|https://www.uniprot.org/uniprot/O02852|https://www.uniprot.org/uniprot/E7EU16|https://www.uniprot.org/uniprot/B4DXI3|https://www.uniprot.org/uniprot/B0LPF0|https://www.uniprot.org/uniprot/Q9VJV3 |
T135 | 161-172 | Protein | denotes | angiotensin | https://www.uniprot.org/uniprot/Q10757 |
T136 | 211-215 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 39-52 | http://purl.obolibrary.org/obo/IDO_0000450 | denotes | pathogenicity |
T6 | 259-268 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T15 | 29-38 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T16 | 29-33 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T17 | 108-120 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T18 | 248-258 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T19 | 248-252 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T20 | 259-268 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 108-120 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 108-120 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
58 | 21-25 | Gene | denotes | ACE2 | Gene:59272 |
59 | 142-145 | Gene | denotes | ACE | Gene:1636 |
60 | 211-215 | Gene | denotes | ACE2 | Gene:59272 |
76 | 29-38 | Species | denotes | SARS-CoV2 | Tax:2697049 |
83 | 108-120 | Disease | denotes | hypertension | MESH:D006973 |
84 | 248-268 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-269 | Sentence | denotes | Owing to the role of ACE2 in SARS-CoV2 pathogenicity, it has been speculated that medical conditions, i.e., hypertension, and/or drugs, i.e., ACE inhibitors and angiotensin receptor blockers, known to influence ACE2 density could alter the fate of SARS-CoV-2 infection. |